Preview Mode Links will not work in preview mode

Apr 9, 2020

Proceedings from the Second Annual Miami General Medical Oncology Symposium — Part 6: Gynecologic Cancers. Featuring perspectives from Drs Michael J Birrer and Kathleen Moore on ovarian, cervical and endometrial cancer.

  • Front-Line Ovarian Cancer: Is PARP Inhibitor Maintenance Therapy the New Standard? — Dr...

Apr 6, 2020

Year in Review: Proceedings from a Multitumor Regional Symposium Focused on the Application of Emerging Research Information to the Care of Patients with Common Cancers — Part 6: Gynecologic Cancers — featuring perspectives from Dr Armstrong and Dr Liu on the management of gynecologic cancers.
CME information and...

Dec 17, 2019

A presentation on ovarian cancer featuring perspectives from Dr David M O’Malley.

  • Introduction (00:00)
  • PARP Inhibitors in the Management of Newly Diagnosed OC; Genetic Drivers of OC Development and Current Testing Algorithms (1:06)
  • Role of PARP Inhibition in the Management of Recurrent OC (19:06s)
  • Prevention,...

Jul 10, 2019

Proceedings from a CME symposium held at the 2019 ASCO Annual Meeting. Featuring perspectives from Prof Jonathan A Ledermann and Drs Joyce F Liu and David M O’Malley.

  • Introduction
  • Program overview: Dr Love (00:00)
  • Genetic Drivers of Ovarian Cancer Development and Current Testing Algorithms; PARP Inhibitors in the...

Jun 27, 2019

Investigator Perspectives on the Current and Future Management of Newly Diagnosed Ovarian Cancer — Part 1: Our most recent one-on-one interview with Dr Monk featuring emerging research and cases from his practice:

  • Guidelines for germline and somatic BRCA testing in ovarian cancer (00:00)
  • Incidence and potential...